Partnering with Alexion to help transform the lives of people affected by rare diseases

Through our strategic client partnerships, Talentmark engages outstanding leaders who are shaping the future of Life Sciences!

Talentmark has partnered with businesses that have spearheaded some of industry’s most important innovations for more than 50 years. Our collaboration with international innovators reflects our own passion and purpose-led approach to making a positive impact.

Global biopharmaceutical company Alexion is the group within AstraZeneca focused on developing life-changing therapies for people living with rare disorders. It was created following the 2021 acquisition of Alexion Pharmaceuticals.

The business describes itself as having an intense desire to pursue the toughest challenges and truly change the world for people living with rare and devastating diseases. A commitment to deliver safe and effective products that meet or exceed the requirements for patients and customers is also paramount.

Aligned with these objectives, Talentmark executive search worked with Alexion to build its clinical safety and pharmacovigilance teams on the East Coast. Other senior international roles Talentmark has filled for Alexion across Europe include:

We understand that successfully bringing new products to market is not just about breakthrough technology. It also requires a culture of innovation, a growth mindset and the very best leaders. At Talentmark, a growth mindset is hardwired into our DNA and we are uniquely positioned to help identify and attract the top teams and leaders who will generate growth for your business.

Reach out to discuss how we can help you to transform your global human capital capability.